These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30117016

  • 1. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Cao J, Wang Q, Wu G, Li S, Wang Q.
    Int Urol Nephrol; 2018 Oct; 50(10):1811-1819. PubMed ID: 30117016
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
    Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W.
    Cancer Lett; 2016 Nov 01; 382(1):64-76. PubMed ID: 27591936
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Yang Y, Zhang G, Li J, Gong R, Wang Y, Qin Y, Ping Q, Hu L.
    Pathol Res Pract; 2021 Dec 01; 228():153676. PubMed ID: 34753061
    [Abstract] [Full Text] [Related]

  • 4. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y, Xu W, Yang Y, Zhang Z.
    Ann Clin Lab Sci; 2021 May 01; 51(3):310-320. PubMed ID: 34162560
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32869841
    [Abstract] [Full Text] [Related]

  • 7. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali DW, Michalak M, Chen XZ, Tang J.
    Mol Cancer; 2020 Jul 29; 19(1):118. PubMed ID: 32727463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Papadopoulos EI, Yousef GM, Scorilas A.
    Tumour Biol; 2015 May 29; 36(5):3197-207. PubMed ID: 25833690
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, Li H, Chen H.
    Cell Physiol Biochem; 2018 May 29; 47(2):747-758. PubMed ID: 29807360
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer.
    Li B, Xie D, Zhang H.
    Cancer Chemother Pharmacol; 2019 Jul 29; 84(1):187-194. PubMed ID: 31115606
    [Abstract] [Full Text] [Related]

  • 12. MiR-26a-5p Targets WNT5A to Protect Cardiomyocytes from Injury Due to Hypoxia/Reoxygenation Through the Wnt/β-catenin Signaling Pathway.
    Yan G, Wang J, Fang Z, Yan S, Zhang Y.
    Int Heart J; 2021 Sep 30; 62(5):1145-1152. PubMed ID: 34544974
    [Abstract] [Full Text] [Related]

  • 13. MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF.
    Xu Z, Yu Z, Tan Q, Wei C, Tang Q, Wang L, Hong Y.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31171711
    [Abstract] [Full Text] [Related]

  • 14. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G, Ji L, Ke M, Ou Z, Tang N, Li Y.
    Biomed Pharmacother; 2018 Oct 28; 106():523-531. PubMed ID: 29990840
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    Zhang S, Chang YY, Gong YW, Gao YJ, Guo Q, Wang YH, Zhao YL, Wang ZP.
    J Cell Biochem; 2019 Apr 28; 120(4):6347-6360. PubMed ID: 30304549
    [Abstract] [Full Text] [Related]

  • 17. MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy.
    Lu H, Lu S, Yang D, Zhang L, Ye J, Li M, Hu W.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30777929
    [Abstract] [Full Text] [Related]

  • 18. Critical role of miR-26a-5p/Wnt5a signaling in gambogic acid-induced inhibition of gastric cancer.
    Zhang Z, Liang L, Cao G.
    J Biochem Mol Toxicol; 2021 Apr 31; 35(4):e22721. PubMed ID: 33533530
    [Abstract] [Full Text] [Related]

  • 19. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
    Liu F, Liu B, Qian J, Wu G, Li J, Ma Z.
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun 01; 49(6):520-529. PubMed ID: 28459992
    [Abstract] [Full Text] [Related]

  • 20. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ.
    Int J Clin Exp Pathol; 2013 Jun 01; 6(9):1734-46. PubMed ID: 24040438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.